Tenon Medical (NASDAQ:TNON – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Monday, March 10th. Analysts expect Tenon Medical to post earnings of ($3.77) per share and revenue of $0.90 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.
Tenon Medical Trading Down 4.4 %
TNON stock opened at $1.30 on Friday. The stock has a market cap of $4.08 million, a PE ratio of -0.05 and a beta of 1.89. The stock has a 50-day moving average price of $1.62 and a two-hundred day moving average price of $2.50. Tenon Medical has a 1 year low of $1.13 and a 1 year high of $15.79.
Analyst Ratings Changes
Separately, Maxim Group decreased their price objective on Tenon Medical from $22.00 to $8.00 and set a “buy” rating for the company in a report on Friday, November 15th.
About Tenon Medical
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
Recommended Stories
- Five stocks we like better than Tenon Medical
- Retail Stocks Investing, Explained
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- What is a Stock Market Index and How Do You Use Them?
- 3 Stocks to Buy While Others Stay on the Sidelines
- Most Volatile Stocks, What Investors Need to Know
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.